(Q39742025)

14 September 2017

1 reference

title

Immune mechanisms and the action of interferon in chronic hepatitis B virus infection (English)

1 reference

14 September 2017

Immune Mechanisms and the Action of Interferon in Chronic Hepatitis B Virus Infection (English)

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

5 April 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

5 April 2023

author name string

A. O. Vladutiu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A352919

5 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=352919

5 April 2023

publication date

1 January 1978

1 reference

full work available at URL

14 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/08820137809047623

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Immunological Investigations

5 April 2023

published in

1 reference

14 September 2017

volume

7

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

371-382

1 reference

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Administration of human fibroblast interferon in chronic hepatitis-B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Cell-mediated Immunity in Patients Positive for Hepatitis-associated Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Cellular immunity to herpes simplex virus mediated by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

H–2 gene expression is required for T cell-mediated lysis of virus-infected target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Cell-mediated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

H–2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Y-antigen killing by T cells of women is restricted by HLA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

HLA restriction of cell-mediated lysis of influenza virus-infected human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Changes in HL-A antigen profiles on SV40-transformed human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Genetic analysis of patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

HLA-A1, B8-Phenotype Association and HBs Antigenemia Evolution in 440 Hemodialyzed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Associations of hepatitis B surface antigenemia with HLA locus B specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Models for recognition of virally modified cells by immune thymus-derived lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

T cell receptor idiotypes are controlled by genes in the heavy chain linkage group and the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820137809047623

Hepatitis B surface antigen and liver cell carcinoma

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Cellular immunity and hepatitis-associated, Australia antigen liver disease

5 April 2023

9

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis

5 April 2023

11

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

T Cells and B Cells in HBsAg-Positive Patients with Chronic Persistent Hepatitis and Asymptomatic Carriers

5 April 2023

12

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

T and B lymphocytes in acute and chronic hepatitis

5 April 2023

13

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Lymphocyte stimulation in hepatitis B infections

5 April 2023

17

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis

5 April 2023

27

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

5 April 2023

28

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Human cell-mediated cytotoxicity against modified target cells is restricted by HLA

5 April 2023

44

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Journal of Cellular and Comparative Physiology

5 April 2023

47

107

MÖLler G.

1962

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

Graft survival rates and HLA antigen frequencies in renal cadaver transplant recipients with hepatitis B antigenemia

5 April 2023

50

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

HLA antigens in HBs antigen positive chronic active hepatitis

5 April 2023

51

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

A Simple Microabsorption Technique for HL-A Typing

5 April 2023

67

1 reference

https://api.crossref.org/works/10.3109/08820137809047623

5 April 2023

Identifiers

1 reference

14 September 2017

1 reference